Education
About Us
Working with TipRanks
Follow Us
Sana Biotechnology (SANA)
NASDAQ:SANA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ -10.17M |
| Operating Income | $ -272.72M | $ -293.14M | $ -272.56M | $ -356.91M | $ -161.12M |
| EBITDA | $ -255.33M | $ -268.58M | $ -256.94M | $ -345.84M | $ -287.03M |
| Net Income | $ -266.76M | $ -283.25M | $ -269.48M | $ -355.93M | $ -285.31M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 152.50M | $ 205.19M | $ 423.96M | $ 551.00M | $ 378.26M |
| Total Assets | $ 501.02M | $ 565.30M | $ 822.72M | $ 1.13B | $ 730.30M |
| Total Debt | $ 94.20M | $ 104.10M | $ 108.25M | $ 110.94M | $ 71.91M |
| Net Debt | $ -33.37M | $ -29.42M | $ -68.51M | $ -142.09M | $ -52.90M |
| Total Liabilities | $ 250.52M | $ 277.79M | $ 323.40M | $ 400.90M | $ 1.15B |
| Stockholders' Equity | $ 250.50M | $ 287.51M | $ 499.31M | $ 728.50M | $ -421.18M |
| Cash Flow | |||||
| Free Cash Flow | $ -256.58M | $ -273.61M | $ -310.93M | $ -280.92M | $ -161.85M |
| Operating Cash Flow | $ -223.15M | $ -253.58M | $ -290.05M | $ -251.05M | $ -137.98M |
| Investing Cash Flow | $ 17.45M | $ 172.01M | $ 210.56M | $ -245.80M | $ -252.56M |
| Financing Cash Flow | $ 199.75M | $ 31.65M | $ 4.91M | $ 631.75M | $ 435.69M |